Evaluation of analogs of mutacin 1140 in systemic and cutaneous methicillin-resistant Staphylococcus aureus infection models in mice
Mutacin 1140 (Mu1140) is a potent antibiotic against Gram-positive bacteria, such as Staphylococcus aureus. The antibiotic is produced by the oral bacterium Streptococcus mutans and is a member of the epidermin family of type AI lantibiotics. The antibiotic exerts its inhibitory activity by binding...
Main Authors: | Min Ju, Thushinari Joseph, Nopakorn Hansanant, Mengxin Geng, McKinley Williams, Andrew Cothrell, Andrew Riley Buhrow, Frank Austin, Leif Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.1067410/full |
Similar Items
-
Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1
by: LaPointe Gisèle, et al.
Published: (2011-04-01) -
Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus
by: Saswati Biswas
Published: (2023-02-01) -
Lantibiotics Produced by Oral Inhabitants as a Trigger for Dysbiosis of Human Intestinal Microbiota
by: Hideo Yonezawa, et al.
Published: (2021-03-01) -
Screening for inhibitors of mutacin synthesis in Streptococcus mutans using fluorescent reporter strains
by: Priyanka Premnath, et al.
Published: (2018-03-01) -
Antimicrobial resistance in methicillin-resistant staphylococcus aureus
by: Bandar Ali Alghamdi, et al.
Published: (2023-04-01)